'Nếu tôi có một quỹ phòng hộ, tôi sẽ chữa bệnh tiểu đường': cơ chế nội sinh để tạo ra hàng hóa công cộng

Anomaly J (2015) Public goods and government action. Polit Philos Econ 14(2):109–128 Arrow K (1963) Social choice and individual values. Wiley, New York Azoulay P, Graff-Zivin F (2018) One superstar funeral at a time. Science 361(6408):1195 Bateman B (2015) Analyzing Market Failure: Adam Smith and John Maynard Keynes. Hist Polit Econ 47(1):127–144 Bator F (1958) The anatomy of market failure. Q J Econ 72(3):351–379 Benkler Y (2006) The wealth of networks: how social production transforms markets and freedom. Yale University Press Berndt R, Hurvitz J (2005) vaccine advance-purchase agreements for low-income countries: practical issues. Health Aff 24(3):653–665 Berndt ER, Glennerster R, Kremer MR, Lee J (2007) Advance market commitments for vaccines against neglected diseases: estimating costs and effectiveness. Health Econ 16:491–511 Bock J (1964) Fiddler on the roof: (from the Broadway Musical “Fiddler on the roof”) RCA Victor Boldrin M, Levine D (2013) The case against patents. J oEcon Perspect 27(1):3–22 Booth BL (2009) Beyond the biotech IPO: a brave new world. Nat Biotechnol 27:705–709 Brunt L, Lerner J, Nicholas T (2012) Inducement prizes and innovation. J Ind Econ 60(4):657–696 Cernuschi T, Furrer E, Schwalbe N, Jones A, Berndt E, McAdams S (2011) Advance market commitment for pneumococcal vaccines: putting theory into practice. Bul World Health Org 89(12):913–918 Chandy RK, Tellis GJ (1998) Organizing for radical product innovation: the overlooked role of willingness to cannibalize. J oMark Res 35(4):474–487 Christensen C (1997) The innovator’s dilemma: when new technology causes great firms to fail. Harvard Business Review Press Clancy M, Moschini G (2013) Incentives for Innovation: patents prizes and research contract. Appl Econ Perspect Policy 35(2):206–241 Cookson C (2020) Gates foundation to concentrate on coronavirus. Financial Times, Berlin Davis S, Button-Simons K, Bensellak T et al (2019) Leveraging crowdsourcing to accelerate global health solutions. Nat Biotechnol 37:848–850 Desowitz R (1991) The Malaria capers: tales of parasites and people. W.W. Norton, New York Ellsberg D (1961) Risk, ambiguity, and the savage axioms. Q J Econ 75(4):643–669 Fernandez JM, Stein RM, Lo AW (2012) Commercializing biomedical research through securitization techniques. Nat Biotechnol 30:964–975 Fernandez JM, Lo AW, Stein RM (2013) Can financial engineering cure cancer? Am Econ Rev 103:406–411 Fleming L (2001) Recombinant uncertainty in technological search. Manag Sci 47:117–132 Ford D, Nelson B (2014) The view beyond venture capital. Nat Biotechnol 32:15–23 Gambardella A (1995) Science and innovation: the US pharmaceutical industry during the 1980s. Cambridge University Press, Cambridge GAVI The Vaccine Alliance (2017) Advance market commitment for pneumococcal vaccines, Annual Report 1 Jan–31 December 2017 Gewin V (2017) Grand challenges. Nature 551:129–131 Glennerster R, Kremer M, Williams H (2006) Creating markets for vaccines. Innov Winter 1(1):67–79 Grabowski H (2008) Follow-on Biologics: data exclusivity and the balance between innovation and competition. Nat Rev Drug Discov 7:479–488 Hardin G (1968) The Tragedy of the Commons. Science 162(3859):1243–1248 Heller M, Eisenberg R (1998) Can patents deter innovation? The anticommons in biomedical research. Science 280(5364):698–701 Hill S, Heiser L, Cokelaer T et al (2016) (2016), Inferring causal molecular networks: empirical assessment through a community-based effort. Nat Methods 13:310–318 Hudson V (2001) Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation. Free Radic Biol & Med 30(12):1440–1461 Kalil T (2006) Prizes for Technological Innovation, Discussion Paper 2006–08. The Hamilton Project, Brookings Institution, Washington DC KEI Research Note (2008) Selected innovation prizes and Reward Programs, Washington, DC Keynes J (1936) The general theory of employment, interest and money. Macmillan, London Knight F (1921) Risk, uncertainty and profits. Schaffner & Marx; Houghton Mifflin Company, Boston KPMG (2017) American Diabetes Association, Consolidated Financial Statements and Consolidated Schedules. http://main.diabetes.org/dorg/PDFs/Financial/ADA2017ConsolidatedFinancials.pdf. Accessed 31 Dec 2017 Kremer M, Williams H (2010) Incentivizing innovation: adding to the toolkit. In: Lerner J, Stern S (eds) Innovation policy and the economy, vol 10. University of Chicago Press, Chicago Levine D (2009) Eyes on the Prize? Sci 323(5919):1296–1297 Marx K, Engels F (1848) The Communist Manifesto. London, Chicago, Ill. :Pluto Press, 1996 Maxmen A. (2018), Scientists Stunned to as Medical Non-Profit Group Abruptly Ends Research Grants, Nature News, August 2 McKinsey & Company (2019) And the winner is … Capturing the promise of philanthropic prizes. Research Report Medema S (2007) The hesitant hand: Mill Sidgwick, and the evolution of the theory of market failures. Hist Polit Econ 39(3):331–358 Meloso D, Copic J, Bossaerts P (2009) Promoting intellectual discover: patents versus markets. Science 323(5919):1335–1339 Miller W (2014) Woo-Hoo, i found a cure. https://www.gocomics.com/nonsequitur/2014/06/24. Accessed 24 June 2014 Mueller-Langer F (2013) Neglected infectious diseases: are push and pull incentive mechanisms suitable for promoting drug development research? Health Econ Policy Law 8(2):185–208 Murray F, Stern S, Campbell G, MacCormack A (2012) Grand innovation prizes: a theoretical, normative and empirical evaluation. Res Policy 41:1779–1792 Murray F, Aghion P, Dewartripont M, Kolev J, Stern S (2016) Of mice and academics: examining the effect of openness on innovation. Am Econ J Econ Policy 8(1):212–252 National Institute of Health (2019) Estimates of funding for various research condition, and disease categories (RCDC). https://report.nih.gov/categorical_spending.aspx. Accessed 19 Apr 2019 Nelson R, Winter SG (1982) An evolutionary theory of economic change. Belkap, Cambridge Pavitt K (1963) Research, innovation and economic growth. Nature 200(4903):206–210 Pollack A (2014) Deal by cystic fibrosis foundation raises cash and some concerns. New York Times Reich M (2000) The Global Drug Gap. Sci 287(5460):1979–1981 Richards L (2002) A mother’s fight against CF. Modern Drug Discov 5(4):19–20 Sampat B, Williams H (2019) How do patents affect follow-on Innovation? Evidence from the Human Genome. Am Econ Rev 109(1):203–236 Samuelson P (1969) Pure theory of public expenditure and taxation. In: Margolis J, Guitton H (eds) Public economics: an analysis of public production and consumption and their relations to the private sectors. Macmillan, London Samuelson P (1970) Economics: an introductory analysis, 8th edn. McGraw-Hill Schwartz J (2004) Private rocket ship visits space again to win $10 million prize. New York Times Sobel D (1996) Longitude: The true story of a lone genius who solved the greatest scientific problem of his time. Penguin Press, New Your Sorensen I (2012) Crowdsourcing and outsourcing: the impact of online funding and distribution on the documentary film industry in the UK. Media Cult Soc 34(6):726–743 Stamp J (1933) Must science ruin economic progress. Nature 132(3333):429–432 Stephan P (2015) How economics shapes science. Harvard University Press Tellis GJ (2013) Unrelenting innovation: how to create a culture for market dominance. John Wiley & Sons Vanderbilt T (2019) “Reverse Innovation” could save lives. Why aren’t we embracing it? The New Yorker Visca A, Bishop C, Hilton S, Hudson V (2008) Improvement in clinical markers in CF patients using a reduced glutathione regimen: an uncontrolled, observational study. J Cystic Fibros 7:433–436 Visca A, Bishop C, Hilton S, Hudson V (2015) Oral reduced l-glutathione improves growth in pediatric cystic fibrosis patients. J Pediatr Gastroenterol Nutr 60(6):802–810 Whiting P, Burgers L, Westwood M, Ryder S, Hoogendoom M, Armstrong N, Allen, A, Severens, H, Kleijnen J (2014) Ivacoftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis, Health Technol Assess, no 18.18, Southampton (UK): NIHR Journals Library Williams H (2012) Innovation inducement prizes: connecting research to policy. J Policy Anal Manag 31(3):752–776 Williams H (2013) Intellectual property rights and innovation: evidence from the human genome. J oPolit Econ 121(1):1–27 Williams H (2018) On the shoulders of giants. Science 361(6408):1195